Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma by O'Hanlon, D.M, Fitzsimons, H, Lynch, J, Tormey, S, Malone, C, Given, H.F

Get full text

Tamoxifen and arimidex do not inhibit angiogenesis in vitro by Tormey, S., Garvin, J., Curran, C., Canney, M., Malone, C., Given, H.F.

Get full text

The prognostic significance of CD44s and CD44v6 expression in stage two breast carcinoma: an immunohistochemical study by Morris, S.F., O»Hanlon, D.M., McLaughlin, R., McHale, T., Connolly, G.E., Given, H.F.

Get full text

The androgen receptor exon 1 trinucleotide repeat does not act as a modifier of the age of presentation in breast cancer by Given, H.F., Radbourne, R., Oag, H., Merritt, S., Barclay, E., Hanby, A.M., Lamlum, H., McGrath, J., Curran, C., Tomlinson, I.P.M.

Get full text

The prognostic value of the tumor marker CA 15-3 at initial diagnosis of patients with breast cancer by McLaughlin, R, McGrath, J, Grimes, H, Given, H F

Get full text

The predictive of tumour markers CA 15-3, TPS and CEA in breast cancer recurrence by Given, M., Scott, M., Mc Grath, J.P., Given, H.F.

Get full text

0-36. An assessment of tissue polypeptide specific antigen (TPS) in the management of breast carcinoma by Mulhall, K., O'Hanlon, D.M., Grimes, H., Given, H.F.

Get full text

0-84. Is measurement of CEA of benefit during follow up in patients with primary breast carcinoma by McLaughlin, R., O'Hanlon, D.M., Grimes, H., Given, H.F.

Get full text

Oestrogen receptor status determines oncological benefits of laparoscopic oophorectomy by Given, M., Scott, M., McGrath, J.P., Given, H.F.

Get full text

Tissue polypeptide specific antigen (TPS) in breast cancer—an initial evaluation by O'Hanlon, D.M., Kerin, M.J., O'Boyle, C., Grimes, H., Given, H.F.

Get full text

Linkage analysis and the susceptibility gene (BRCA-1) in familial breast cancer by Kent, P., O'Donoghue, J.M., O'Hanlon, D.M., Kerin, M.J., Maher, D.J., Given, H.F.

Get full text